Jeff Passer, M.D.（Omaha, NE）

Passer Restorative Therapies, led by Jeffrey A. Passer, M.D., FACP, operates in Omaha, Nebraska, providing hormone replacement therapy, weight management, and anti-aging medicine to adult patients seeking metabolic and endocrine optimization. Dr. Passer is board-certified in internal medicine and holds Fellowship status with the American College of Physicians, bringing decades of clinical experience to the evaluation and treatment of age-related hormonal decline, thyroid disorders, and metabolic dysfunction. The practice integrates conventional internal medicine with restorative approaches, allowing patients to address chronic conditions through both evidence-based hormone modulation and pharmaceutical interventions.

The clinic offers semaglutide therapy as a primary tool for weight management, prescribed following comprehensive metabolic assessment and individualized dosing protocols. Semaglutide, a GLP-1 receptor agonist, is used to support appetite regulation, glycemic control, and sustained weight reduction in patients who meet clinical criteria. Treatment plans typically include baseline laboratory evaluation, body composition analysis, and ongoing monitoring to adjust dosing and assess response. Dr. Passer’s internal medicine background enables him to manage patients with comorbid conditions such as prediabetes, hypertension, and dyslipidemia concurrently with weight loss therapy, ensuring safe and coordinated care.

Hormone replacement therapy at Passer Restorative Therapies addresses testosterone deficiency in men and estrogen or progesterone imbalances in women, using bioidentical and FDA-approved hormone formulations tailored to symptom presentation and laboratory findings. Thyroid optimization is a core component of the practice, with Dr. Passer evaluating patients for subclinical hypothyroidism, Hashimoto’s thyroiditis, and thyroid resistance syndromes that may contribute to fatigue, weight gain, and cognitive changes. Treatment protocols are adjusted based on free T3, free T4, reverse T3, and TSH levels, with the goal of achieving symptomatic relief rather than solely normalizing lab ranges. Patients with complex thyroid cases or those dissatisfied with standard levothyroxine monotherapy often seek consultation for alternative dosing strategies or combination therapy.

Patients schedule initial consultations to review medical history, current symptoms, and treatment goals, followed by phlebotomy for hormone panels, metabolic markers, and nutrient levels as indicated. Follow-up visits occur at intervals determined by treatment type, with semaglutide patients typically seen monthly during titration and quarterly once stable. Thyroid and hormone replacement patients are monitored every three to six months with repeat labs to assess therapeutic response and make necessary adjustments. The practice handles billing and insurance coordination through its front office, and patients are advised to confirm coverage for specific services prior to treatment initiation. Communication regarding lab results, prescription refills, and appointment scheduling is managed by the receptionist team during standard business hours.

Passer Restorative Therapies serves patients throughout the Omaha metropolitan area and surrounding Nebraska communities, offering in-person consultations at the clinic location. The practice does not currently advertise telehealth services, focusing instead on face-to-face evaluation and hands-on clinical assessment. Dr. Passer’s approach emphasizes thorough diagnostic workup and individualized treatment plans rather than protocol-driven care, making the practice suitable for patients seeking a physician-led model with direct access to a board-certified internist. Those interested in semaglutide for weight loss, thyroid optimization beyond standard care, or hormone replacement therapy managed by a fellowship-trained physician can contact the office to schedule a new patient appointment and discuss treatment options.